POSTER SESSION V
Wednesday, March 5, 2008   —  9:30 AM - 12:00 Noon
Convention Center Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


DERMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
51 Cdc7 in Melanomas, Spitz Tumors, and Melanocytic Nevi (416)
LE Clarke, J Hennessy, TJ Fountaine, RD Bruggeman, JT Clarke, KF Helm - Penn State Hershey Medical Center, Hershey, PA 		Add
52 Preserved Topographic Gradient of Cell Cycle Regulator Microsatellites Abnormalities and Regressive Cell Kinetics Characterizes Spitz Tumors (426)
EA Husain, L Pozo, A Blanes, SJ Diaz-Cano - King's College Hospital, London, United Kingdom; Homerton University Hospital, London, United Kingdom; University of Malaga School of Medicine, Malaga, Spain 		Add
53 Interobserver Variability in Differentiation of Nodal Nevus from Melanoma Micrometastasis in Sentinel Lymph Adenectomy Specimens (409)
N Cetin, M Bannan, F Darvishian, C Hajdu, D Nonaka, W Ye, Z Pei, J Melamed - NYU, New York; Karolinska Inst, Stockholm, Sweden 		Add
54 High-Grade Atypical Melanocytic Nevi Show Kinetic and Microsatellite Features of Progression at the Junctional Compartment (425)
EA Husain, L Pozo, A Blanes, SJ Diaz-Cano - Homerton University Hospital, London, United Kingdom; University of Malaga School of Medicine, Malaga, Spain; King's College Hospital, London, United Kingdom 		Add
55 Prospective Evaluation of an Extended Histologic Protocol for Detection of Melanoma Micrometastasis (410)
N Cetin, M Bannan, B Wang, J Melamed - New York University Medical Center, New York, NY 		Add
56 Laminin/Integrin Expression Profile in Malignant Melanoma (469)
K Wong, MP Marinkovich, BA Horst - Stanford University School of Medicine, Stanford, CA; Columbia University School of Medicine, New York, NY 		Add
57 The Borderline Melanocytic Proliferation: A Clinical and Pathological Study with a Categorical Approach to Diagnostic Assessment (457)
JT Schaefer, CM Magro, AN Crowson - Weill Medical College of Cornell University, New York, NY; St. John Medical Center, Tulsa, OK 		Add
58 H2A.X Phosphorylation in Melanocytic Lesions: Expression in Malignant Melanoma and Melanocytic Nevi with Severe Architectural and Cytologic Atypia (414)
WL Cheung, JM Moresi, GJ Netto - Johns Hopkins Hospital, Baltimore, MD 		Add
59 MFG-E8 Expression in Malignant Melanoma and Benign Melanocytic Nevi (428)
MM Johnson, NA Belsley, M Jinushi, DR Carrasco, G Dranoff, MC Mihm - Massachusetts General Hospital, Boston; Beth Israel Deaconess Hospital, Boston; Dana-Farber Cancer Institute, Boston 		Add
60 PRL-3 Expression - Possible Prognostic and Predictive Marker in Primary Cutaneous Melanoma (437)
MG Lim, D Lawson, G Cotsonis, XJ Chang, C Shou, IM Stein, C Cohen - Emory University Hospital, Atlanta, GA; Attogen Biomedical Research, Worcester, MA; Beijing Institute for Cancer Research, Beijing, China; Monogenics Ltd., Chestnut Hill, MA 		Add
61 PRL-3 Protein Expression in Sinonasal and Cutaneous Melanoma (438)
MG Lim, JB Arbiser, D Lawson, C Shou, XJ Chang, IM Stein, S Muller, C Cohen - Emory University Hospital, Atlanta, GA; Beijing Institute for Cancer Research, Beijing, China; Attogen Biomedical Research, Worchester, MA; Monogenics Ltd., Chestnut Hill, MA 		Add
62 Severe Architectural Disorder Is a Potential Pitfall in the Diagnosis of Small Dysplastic Nevi (464)
CA Torres-Cabala, JA Plaza, AH Diwan, VG Prieto - University of Texas - MD Anderson Cancer Center, Houston, TX 		Add
63 Expression of MSH2 in Combination with CYCLIN D1 Can Distinguish Benign Nevi from Maligant Melanocytic Tumors (413)
CH Chen, A Rajput, H Feilotter, T Radcliffe, M Akbari, VA Tron - Kingston General Hospital, Queen's University, Kingston, ON, Canada; University of British Columbia, Vancouver, BC, Canada; Predictive Patterns Software Inc, Kingston, ON, Canada 		Add
64 Alteration of the Epigenetic Regulation of Chromatin Structure and Aggressiveness of Skin Melanoma (462)
S Staibano, M Mascolo, L Insabato, G Ilardi, C Mignogna, E Mezza, M Scalvenzi, G De Rosa - University Federico II of Naples Faculty of Medicine and Surgery, Naples, Italy 		Add
65 Elastin Immunostain Distinguishes the Elastic Fiber Network in Malignant Melanomas with Regression from Melanomas with Scarring Fibrosis (429)
H Kamino, S Tam, S Toussaint - New York University School of Medicine, New York, NY; Hospital Manuel Gea Gonzalez, Mexico, DF, Mexico 		Add
66 Can Histology of Recurrence Distinguish Banal from Dysplastic Nevi? (443)
EC Miller, SR Tahan - Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA 		Add
67 Nevic Cell Aggregates in Sentinel Lymph Node Biopsies: Incidence in Melanoma vs Non-Melanoma Malignancies and Diagnostic Pitfalls (431)
FA Khokhar, M Garcia-Moliner - Tufts - New England Medical Center, Boston, MA 		Add
68 FoxP3+ CD4+ T Regulatory Cells and Survival in Melanoma (430)
H Kamino, R Walters, S Tam, H Ratech - New York University School of Medicine, New York, NY; Albert Einstein Medical College, Bronx, NY 		Add
69 Is Immunohistochemical Analysis of DNA Mismatch Repair Proteins in Unselected Sebaceous Neoplasms Warranted as a Screening Test for Muir-Torre Syndrome? (419)
ZP Elaba, D Mandich, RW Cartun, S Ligato - Hartford Hospital, Hartford, CT 		Add
70 Intra- and Peri-Tumoral Lymphocytic Response Is Associated with Loss of DNA Mismatch Repair Protein in Sebaceous Neoplasms (446)
L Orta, D Klimstra, P Mecca, L Tang, K Busam, J Shia - Memorial Sloan-Kettering Cancer Center, NY 		Add
71 The Value of Skin Sebaceous Gland Tumors in the Diagnosis of Muir-Torre Syndrome by Immunohistochemical and Molecular Evaluation of MLH1, MSH2 and MSH6 Genes (427)
M Idoate, R Zarate, A Cordoba, I Sanchez-Carpintero, M Robles, J Echeveste, T Tunon, J Garcia-Foncillas, MD Lozano, A Panizo - University of Navarra, Pamplona, Navarra, Spain; Navarra Hospital, Pamplona, Navarra, Spain 		Add
72 CD25 Expression in Cutaneous Mast Cell Lesions: Differential Expression in Cutaneous and Systemic Mastocytosis (423)
JL Herrick, LA Erickson, TJ Flotte - Mayo Clinic, Rochester, MN 		Add
73 Immunohistochemistry in Ocular Carcinomas (461)
BW Sramek, AE Lisle, TS Loy - University of Missouri-Columbia, Columbia, MO 		Add
74 HER-2/Neu Expression in Extramammary Paget Disease: A Clinicopathologic and Immunohistochemistry Study of 47 Cases with and without Underlying Malignancies (449)
JA Plaza, C Torres-Cabala, D Ivan, VG Prieto - M.D. Anderson Cancer Center, Houston, TX 		Add
75 Is Mammaglobin Expression Helpful in Differentiating Mammary from Extramammary Pagets' Disease and in the Differential Diagnosis of Pagetoid Neoplasms of the Skin? (415)
TL Cibull, BC Gleason, S Badve, BR Smoller, KM Hiatt - University of Arkansas Medical School, Little Rock, AR; Indiana University, Indianapolis, IN 		Add